4//SEC Filing
Zeskind Benjamin J. 4
Accession 0001790340-24-000006
CIK 0001790340other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:07 PM ET
Size
7.4 KB
Accession
0001790340-24-000006
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Award
Stock Option
2024-02-08+16,414→ 16,414 totalExercise: $6.70Exp: 2029-02-08→ Class A Common Stock (16,414 underlying) - Award
Stock Option
2024-02-08+244,286→ 244,286 totalExercise: $6.09Exp: 2034-02-08→ Class A Common Stock (244,286 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870062
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:07 PM ET
- Size
- 7.4 KB